BRTX Stock Summary and Trading Ideas (Biorestorative Therapies | NASDAQ:BRTX)

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

Biorestorative Therapies trades on the NASDAQ stock market under the symbol BRTX.

As of March 11, 2026, BRTX stock price declined to $0.28 with 6,258,794 million shares trading.

BRTX has a beta of 0.91, meaning it tends to be less sensitive to market movements. BRTX has a correlation of 0.01 to the broad based SPY ETF.

BRTX has a market cap of $6.01 million. This is considered a Sub-Micro Cap stock.

Last quarter Biorestorative Therapies reported $11,800 in Revenue and -$.33 earnings per share. This fell short of revenue expectation by $-424,200 and exceeded earnings estimates by $.05.

In the last 3 years, BRTX traded as high as $7.13 and as low as $.19.

The top ETF exchange traded funds that BRTX belongs to (by Net Assets): VXF.

BRTX has underperformed the market in the last year with a return of -81.9%, while the SPY ETF gained +21.9%. In the last 3 month period, BRTX fell short of the market, returning -74.7%, while SPY returned -1.3%. However, in the most recent 2 weeks BRTX has outperformed the stock market by returning +3.2%, while SPY returned -1.6%.

BRTX support price is $.26 and resistance is $.31 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BRTX shares will trade within this expected range on the day.